For Agile Marketing Success, Be "Multi-Minded"

Posted by Erin Liman on Fri, Jan 31, 2020

MaryAnn Godwin and Sean Sinisgalli co-wrote this blog post with Erin Liman.

For healthcare marketers, agile marketing transformations are essential in adapting to today’s data-driven, customer focused, rapid response world. Making an agile marketing transformation means avoiding four main pitfalls, the first of which is not recognizing and solving problems analytically and creatively — what we call “multi-mindedness.”


>
Read More

Going Global With Analytics: Plan Before You Leap

Posted by Pragati Lodha on Mon, Jan 20, 2020

Iain Fratter co-wrote this post with Pragati Lodha 


>
Read More

AI & User Experience: As Always, the User Comes First

Posted by Arun Shastri on Mon, Nov 18, 2019

This blog post is the sixth in a series on the impact that AI will have on different business aspects of pharma.

While most of us are aware of the importance of user experience, UX goes beyond simply developing a relevant and usable interface for software. UX is a discipline that requires a thorough understanding of users’ needs and the context in which they use technology. Whatever solution you may roll out to users, good UX is about meeting those needs.


>
Read More

AI & Analytics Consumption: Insights on Demand

Posted by Arun Shastri on Wed, Oct 02, 2019

This blog post is the fifth in a series on the impact that AI will have on different business aspects of pharma.

The past few years have seen an explosion of data, and with it, the need to make use of it. Gathering and stitching together internal and external data sources presents one set of challenges, but what about the analysts who struggle to leverage all of this data? How can they keep up with increasing demands for data-driven insights from the entire organization? How can we empower the whole organization to have access to these critical insights? Here’s a hint: AI is part of the solution.


>
Read More

Boost Patient Recruitment With Data-Centric Trial Planning

Posted by Venkat Sethuraman on Fri, Aug 16, 2019

Denise N. Bronner, Gaurav A. Singh and Ray Zhong co-wrote this blog post with Venkat Sethuraman

A common struggle for pharmaceutical companies is poor patient recruitment for clinical trials. As a consequence, 80% of clinical trials fail to meet their enrollment goals, suffer delayed timelines and absorb skyrocketing R&D costs. Ultimately, the patient suffers from delays in the release of needed therapies. Currently, pharmaceutical companies are partnering with trial matching startups to enhance clinical study design, matching and data collection. With analytics and platforms, pharmaceutical companies are beginning to streamline the clinical trial process in hopes of increasing new entrants to the market.


>
Read More